Form 4: Synopsys CFO Sells Shares Under 10b5-1 Plan

Synopsys Inc. CFO Shelagh Glaser executed a Rule 10b5-1 trading plan, resulting in the sale of 3,394 shares of common stock.

Summary

• Shelagh Glaser, Chief Financial Officer of Synopsys Inc. (SNPS), reported transactions on June 12, 2026.
• These transactions were conducted under a pre-established Rule 10b5-1 trading plan adopted on January 13, 2026.
• Glaser sold 3,394 shares of Synopsys common stock at a weighted average price of $450.02 per share.
• The sales occurred at prices ranging from $450.00 to $457.95.
• Following these sales, Glaser directly beneficially owns 14,358 shares of common stock.
• Additionally, 17,752 shares were transferred to the Karl and Shelagh Glaser Revocable Trust, in which Glaser indirectly holds beneficial ownership.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing neutrally; while insider selling can be a negative signal, the use of a Rule 10b5-1 plan indicates a structured and compliant approach to the transactions.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned and potentially non-insider trading related sales.
• The sales occurred at prices reflecting the company's market valuation, with a weighted average of $450.02.

Negatives

• A significant number of shares were sold by a key executive, which could be perceived negatively by the market.
• The total value of the shares sold is approximately $1.53 million (3,394 shares * $450.02).

Risks

• Potential for negative market perception due to insider selling, even if conducted under a 10b5-1 plan.
• The weighted average sale price of $450.02 indicates a high valuation for the stock at the time of sale.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports on past transactions.

Management Comments

• The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted January 13, 2026.
• The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

Industry Context

StockSavvy.ai notes that insider selling, particularly by C-suite executives like a CFO, is a common event. However, the execution of these sales under a Rule 10b5-1 plan is designed to mitigate concerns about trading on material non-public information. The high average sale price suggests the stock is trading at a premium, which is typical for established technology companies in the semiconductor design sector.

Related Party Transactions

• Transfer of 17,752 shares to the Karl and Shelagh Glaser Revocable Trust, which is exempt from Section 16 reporting under Rule 16a-13.

Stakeholder Impact

• Shareholders: May interpret the sale as a signal of reduced confidence or a need for liquidity by a key executive, although the 10b5-1 plan mitigates this concern.
• Employees: The stock price performance, influenced by such events, can impact employee stock options and grants.
• Creditors: No direct impact is anticipated from this transaction.

Next Steps

• The reporting person will continue to hold 14,358 shares directly and indirectly through the Karl and Shelagh Glaser Revocable Trust.

Key Dates

Keywords

Synopsys, SNPS, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, CFO, Shelagh Glaser, Beneficial Ownership, Securities Exchange Act